2011 10-K

• Read more about 2011 10-K

2004 Annual Report

• Read more about 2004 Annual Report

Alnylam Pharmaceuticals Q3 2019 Earnings Conference Call

• Read more about Alnylam Pharmaceuticals Q3 2019 Earnings Conference Call

2019 RNAi Roundtable: Lumasiran, in Development for the Treatment of Primary Hyperoxaluria Type 1

• Read more about 2019 RNAi Roundtable: Lumasiran, in Development for the Treatment of Primary Hyperoxaluria Type 1

2019 RNAi Roundtable: Givosiran, in Development for the Treatment of Acute Hepatic Porphyria

• Read more about 2019 RNAi Roundtable: Givosiran, in Development for the Treatment of Acute Hepatic Porphyria

2019 Cantor Global Healthcare Conference

• Read more about 2019 Cantor Global Healthcare Conference

2019 RNAi Roundtable: Patisiran & Vutrisiran, for the Treatment of Transthyretin Mediated Amyloidosis

• Read more about 2019 RNAi Roundtable: Patisiran & Vutrisiran, for the Treatment of Transthyretin Mediated Amyloidosis

17th Annual Morgan Stanley Global Healthcare Conference

• Read more about 17th Annual Morgan Stanley Global Healthcare Conference

Alnylam Pharmaceuticals Q2 2019 Earnings Conference Call

• Read more about Alnylam Pharmaceuticals Q2 2019 Earnings Conference Call

Goldman Sachs 40th Annual Global Healthcare Conference

• Read more about Goldman Sachs 40th Annual Global Healthcare Conference